Colin Hislop
Chief Tech/Sci/R&D Officer at EIGER BIOPHARMACEUTICALS, INC.
Colin Hislop active positions
| Companies | Position | Start | End |
|---|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Colin Hislop
Former positions of Colin Hislop
| Companies | Position | Start | End |
|---|---|---|---|
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Chief Tech/Sci/R&D Officer | 2016-03-31 | 2017-09-04 |
| Corporate Officer/Principal | 2017-09-04 | 2017-10-19 | |
| ANTHERA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2010-06-03 | 2016-03-31 |
| Corporate Officer/Principal | 2005-10-31 | 2010-06-03 | |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Chief Tech/Sci/R&D Officer | 2005-05-31 | 2005-05-31 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Chief Tech/Sci/R&D Officer | 2004-08-31 | 2004-08-31 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - | - |
Training of Colin Hislop
| University of London | Doctorate Degree |
| University of Surrey | Undergraduate Degree |
Statistics
International
| United States | 8 |
| United Kingdom | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Commercial Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
- Stock Market
- Insiders
- Colin Hislop
- Experience